Visco Vision Inc. (6782) - Net Assets

Latest as of September 2025: NT$3.98 Billion TWD ≈ $125.50 Million USD

Based on the latest financial reports, Visco Vision Inc. (6782) has net assets worth NT$3.98 Billion TWD (≈ $125.50 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$5.82 Billion ≈ $183.37 Million USD) and total liabilities (NT$1.84 Billion ≈ $57.87 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Visco Vision Inc. asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets NT$3.98 Billion
% of Total Assets 68.44%
Annual Growth Rate 34.32%
5-Year Change 344.6%
10-Year Change N/A
Growth Volatility 68.04

Visco Vision Inc. - Net Assets Trend (2019–2024)

This chart illustrates how Visco Vision Inc.'s net assets have evolved over time, based on quarterly financial data. Also explore Visco Vision Inc. (6782) total assets for the complete picture of this company's asset base.

Annual Net Assets for Visco Vision Inc. (2019–2024)

The table below shows the annual net assets of Visco Vision Inc. from 2019 to 2024. For live valuation and market cap data, see 6782 stock market capitalisation.

Year Net Assets Change
2024-12-31 NT$3.72 Billion
≈ $117.09 Million
+24.61%
2023-12-31 NT$2.98 Billion
≈ $93.96 Million
-4.06%
2022-12-31 NT$3.11 Billion
≈ $97.94 Million
+179.23%
2021-12-31 NT$1.11 Billion
≈ $35.08 Million
+33.19%
2020-12-31 NT$835.89 Million
≈ $26.34 Million
-1.61%
2019-12-31 NT$849.55 Million
≈ $26.77 Million
--

Equity Component Analysis

This analysis shows how different components contribute to Visco Vision Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 227.7% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings NT$1.24 Billion 33.51%
Common Stock NT$630.00 Million 17.04%
Other Components NT$1.83 Billion 49.45%
Total Equity NT$3.70 Billion 100.00%

Visco Vision Inc. Competitors by Market Cap

The table below lists competitors of Visco Vision Inc. ranked by their market capitalization.

Company Market Cap
Itafos Corp
V:IFOS
$449.58 Million
Stitch Fix
NASDAQ:SFIX
$449.67 Million
Politeknik Metal Sanayi ve
IS:POLTK
$449.77 Million
Iljin HySolus Co Ltd
KO:271940
$449.85 Million
Belo Sun Mining Corp.
TO:BSX
$449.54 Million
Hangzhou Coco Healthcare Products Co.Ltd.
SHE:301009
$449.53 Million
Integra Resources Corp
V:ITR
$449.48 Million
Shenzhen Zqgame
SHE:300052
$449.47 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Visco Vision Inc.'s equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 2,964,940,000 to 3,697,047,000, a change of 732,107,000 (24.7%).
  • Net income of 636,471,000 contributed positively to equity growth.
  • Dividend payments of 151,200,000 reduced retained earnings.
  • Other comprehensive income increased equity by 194,181,000.
  • Other factors increased equity by 52,655,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income NT$636.47 Million +17.22%
Dividends Paid NT$151.20 Million -4.09%
Other Comprehensive Income NT$194.18 Million +5.25%
Other Changes NT$52.66 Million +1.42%
Total Change NT$- 24.69%

Book Value vs Market Value Analysis

This analysis compares Visco Vision Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 3.87x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 14.60x to 3.87x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2019-12-31 NT$15.51 NT$226.50 x
2020-12-31 NT$15.10 NT$226.50 x
2021-12-31 NT$20.29 NT$226.50 x
2022-12-31 NT$55.28 NT$226.50 x
2023-12-31 NT$46.99 NT$226.50 x
2024-12-31 NT$58.47 NT$226.50 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Visco Vision Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 17.22%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 17.33%
  • • Asset Turnover: 0.69x
  • • Equity Multiplier: 1.43x
  • Recent ROE (17.22%) is below the historical average (23.29%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2019 37.18% 21.46% 0.81x 2.14x NT$230.94 Million
2020 15.32% 8.39% 0.69x 2.66x NT$44.48 Million
2021 39.85% 22.58% 0.63x 2.81x NT$332.30 Million
2022 20.02% 22.23% 0.52x 1.72x NT$309.01 Million
2023 10.17% 12.58% 0.51x 1.59x NT$5.12 Million
2024 17.22% 17.33% 0.69x 1.43x NT$266.77 Million

Industry Comparison

This section compares Visco Vision Inc.'s net assets metrics with peer companies in the Medical Instruments & Supplies industry.

Industry Context

  • Industry: Medical Instruments & Supplies
  • Average net assets among peers: $1,650,883,600
  • Average return on equity (ROE) among peers: 9.41%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Visco Vision Inc. (6782) NT$3.98 Billion 37.18% 0.46x $449.57 Million
St.Shine Optical Co Ltd (1565) $966.82 Million 24.11% 0.40x $164.40 Million
Maxigen Biotech Inc (1783) $369.25 Million -9.77% 0.32x $109.91 Million
SciVision Biotech Inc (1786) $363.70 Million 14.07% 0.11x $135.56 Million
Bioteque (4107) $2.80 Billion 15.38% 0.38x $252.17 Million
Chi Sheng Chemical (4111) $1.05 Billion 4.04% 0.44x $55.51 Million
BenQ Medical Technology (4116) $1.09 Billion 6.10% 0.54x $56.09 Million
Pacific Hospital Supply Co Ltd (4126) $2.71 Billion 14.28% 0.40x $181.84 Million
Bionime Corp (4737) $2.54 Billion 3.89% 0.80x $151.21 Million
Vizionfocus Inc. (4771) $2.02 Billion 15.48% 0.59x $347.59 Million
Formosa Optical Technology Co Ltd (5312) $2.60 Billion 6.55% 1.44x $183.92 Million

About Visco Vision Inc.

TW:6782 Taiwan Medical Instruments & Supplies
Market Cap
$449.57 Million
NT$14.27 Billion TWD
Market Cap Rank
#13102 Global
#480 in Taiwan
Share Price
NT$226.50
Change (1 day)
+2.95%
52-Week Range
NT$162.00 - NT$235.00
All Time High
NT$369.70
About

Visco Vision Inc. manufactures and sells silicone hydrogel contact lenses in Asia, Europe, and the Americas. The company offers spherical, multifocal, toric, cosmetic, and color lenses. It also provides medical and lease management services. The company was incorporated in 1998 and is based in Taoyuan City, Taiwan.